Please login to the form below

Not currently logged in
Email:
Password:

drug shortage

This page shows the latest drug shortage news and features for those working in and with pharma, biotech and healthcare.

Not in my backyard

Not in my backyard

I think we’re all for lowering drug prices. And I know we’re all for helping patients access affordable medicine. ... The idea that one can turn to a neighbour for a solution is, at best, a short-term solution reserved for the most extreme cases like

Latest news

  • FDA launches drug shortages mobile app FDA launches drug shortages mobile app

    Valerie Jensen, associate director of the Drug Shortage Staff in the FDA's Center for Drug Evaluation and Research, said: “ The FDA understands that healthcare professionals and pharmacists need real-time ... The new mobile app is an innovative tool

  • EMA publishes European drug shortage details EMA publishes European drug shortage details

    EMA publishes European drug shortage details. First public list contains details on Cerezyme, Fabrazyme, Increlex and Vistide. ... product. Details include information on the reason for the shortage and the current status of supply.

  • FDA creates drug shortage plan FDA creates drug shortage plan

    FDA creates drug shortage plan. Manufacturers required to give early notice of potential shortfall of important medicines. ... called for in the Food and Drug Administration Safety and Innovation Act (FDASIA).

  • Swift US approval for Baxter’s nutritional supplement Swift US approval for Baxter’s nutritional supplement

    The approval comes after the drug received priority review status from the US regulator due to the shortage of products available for patients in this condition. ... There are a total of 242 products listed in the FDA' drug shortage list, 16 of which are

  • US shortage of GSK’s restless legs syndrome treatment Horizant US shortage of GSK’s restless legs syndrome treatment Horizant

    US shortage of GSK’ s restless legs syndrome treatment Horizant. FDA blames contract manufacturer delays. ... This saw a Complete Response Letter, declining to grant the drug marketing approval, issued in February 2010.

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics